Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)

NCT01088412 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01088412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01088412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Completed
Start date
April 30, 1999
Completion date
September 30, 2015
Enrollment
22,845 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone (gh) deficiency, non-gh-deficient growth disorders, short stature homeobox containing gene (shox) deficiency, shox deficiency-related disorder